SecBot SecBot
8-K ·Filed Aug 24, 2026

VNRX

VOLITIONRX LTD
BEARISH
Impact 6/10
Horizonweeks Processed2mo ago SEC0001477932-26-005251
8-K context-dependent: Items 3.02
Actionable Insight ▼ Bearish

The continued conversion of debt into equity at a micro-cap company signals ongoing cash burn and reliance on a dilutive financing structure. Monitor for further conversions or a potential need for additional financing, which would further pressure the stock price.

DirectionBearish
Confidencehigh
Horizonweeks
Latest settled — T+20d
VNRX ▼ -35.78% at T+20d
SHORT call ✓ call won +35.78% · α vs SPY +36.75% · entry $0.3846 → $0.2470
Next anchor: T+60d in 20d
Latest observation: T+42 -81.94% FF3 residual α
Entry = T+0 close
Aug 24, 2026
via day close
T+1d
-11.80%
call +11.80% · α +11.83%
$0.3392
settled 2mo ago
T+5d
+2.50%
call -2.50% · α -3.04%
$0.3942
settled 8w ago
T+20d
-35.78%
call +35.78% · α +36.75%
$0.2470
settled 5w ago
T+60d
Pending
in 20d

Price Chart

Loading chart...

Executive Summary

VolitionRx issued 773,361 shares of common stock to Lind Global Asset Management XII LLC in August 2026 to satisfy $400,000 in conversion obligations under senior secured convertible promissory notes. The conversions were made under existing note agreements, with no new capital raised, and the shares were issued in reliance on Section 3(a)(9) or Section 4(a)(2) of the Securities Act. This represents ongoing dilution from a pre-existing financing arrangement for a company with a $6M market cap, signaling persistent cash needs and shareholder dilution.

Key Facts

  • Issued 220,264 shares on Aug 11, 2026 to satisfy a $150,000 conversion obligation to Lind Global.
  • Issued 553,097 shares on Aug 20, 2026 to satisfy a $250,000 conversion obligation to Lind Global.
  • Total of 773,361 shares issued for $400,000 in conversion obligations under existing senior secured convertible promissory notes.
  • Original note principal amounts were $7,500,000 and $2,400,000 under a securities purchase agreement dated May 15, 2025.
  • Shares issued without registration under Section 3(a)(9) or Section 4(a)(2) of the Securities Act.
  • Company market cap is approximately $6M, making the 773,361 share issuance highly dilutive relative to outstanding shares.

Financial Impact

773,361 shares issued for $400,000 in conversion obligations; no new capital raised. Dilution is significant relative to a $6M market cap company.

dilutionshare count

Risk Factors

  • Further dilution from remaining convertible note principal of approximately $9.5M.
  • Potential for additional debt conversions at discounted prices, further pressuring the stock.
  • Going concern risk given the company's small market cap and reliance on dilutive financing.

Market Snapshot

Exchange
NYSE
Sector
In Vitro & In Vivo Diagnostic Substances
Analyst Consensus
82% bullish (11 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001477932-26-005251
Document: 0001477932-26-005251-index.html0001477932-26-005251
Document: 0001477932-26-005251.txt0001477932-26-005251
20 reports for VNRX
Performance horizon
100% Hit rate @ T+60 3 of 3 directional calls Went positive at some point 11 of 12 best @ T+60▲ +83.65%Jul 20, 2026
Filters
Rows
Reports for VNRX — sortable, filterable
TypeNow
Oct 27, 2026
today
8-K
NEUTRAL ★ 4/10
$0.1900awaiting T+60—$0.1900 (−0.00%)
Sep 25, 2026
4w ago
8-K
BEARISH ★ 7/10
$0.2529awaiting T+60—$0.1900 (+24.87%)
Sep 16, 2026
5w ago
SC 13D/A
NEUTRAL ★ 3/10
$0.2849awaiting T+60—$0.1900 (−33.31%)
Sep 15, 2026
6w ago
8-K
BEARISH ★ 5/10
$0.2749awaiting T+60—$0.1900 (+30.88%)
Sep 11, 2026
6w ago
EFFECT
BEARISH ★ 7/10
$0.3102awaiting T+60—$0.1900 (+38.75%)
Sep 8, 2026
7w ago
S-3/A
BEARISH ★ 7/10
$0.3400awaiting T+60—$0.1900 (+44.12%)
Sep 1, 2026
8w ago
8-K
BEARISH ★ 6/10
$0.3800awaiting T+60—$0.1900 (+50.00%)
Aug 24, 2026
9w ago
8-K
BEARISH ★ 6/10
$0.3846awaiting T+60—$0.1900 (+50.60%)
Aug 7, 2026
11w ago
8-K
BEARISH ★ 6/10
$0.7700awaiting T+60—$0.1900 (+75.32%)
Jul 20, 2026
14w ago
EFFECT
BEARISH ★ 6/10
$1.13 $0.1847▲ +83.65%▲ +88.50%$0.1900 (+83.19%)
Showing 10 of 20

US Market Status

Market Closed — Opens Thu (11h 34m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 24, 2026